Patents by Inventor Ravichandran Mahalingam

Ravichandran Mahalingam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND DOSAGE FORMS FOR TREATMENT OF HPV INFECTION AND HPV-INDUCED NEOPLASIA
    Publication number: 20240150381
    Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 9, 2024
    Applicant: Antiva Biosciences, Inc.
    Inventors: Barry Aldous, Ramakrishna Gadiraju, Sarah Walter, Oranee Daniels, Gail Maderis, Ankush Argade, Ravichandran Mahalingam, Zhengle Zhao, Zhaoyang Qin, Siyi Jiang, Runyan Li
  • TREATMENT OF HPV-INDUCED NEOPLASIA
    Publication number: 20240139221
    Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 2, 2024
    Applicant: Antiva Biosciences, Inc
    Inventors: Barry Aldous, Ramakrishna Gadiraju, Sarah Walter, Oranee Daniels, Gail Maderis, Ankush Argade, Ravichandran Mahalingam, Zhengle Zhao, Zhaoyang Qin, Siyi Jiang, Runyan Li
  • TREATMENT OF HPV INFECTION
    Publication number: 20240139220
    Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 2, 2024
    Applicant: Antiva Biosciences, Inc.
    Inventors: Barry Aldous, Ramakrishna Gadiraju, Sarah Walter, Oranee Daniels, Gail Maderis, Ankush Argade, Ravichandran Mahalingam, Zhengle Zhao, Zhaoyang Qin, Siyi Jiang, Runyan Li
  • Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and Use
    Publication number: 20220347210
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: July 11, 2022
    Publication date: November 3, 2022
    Applicant: Unicycive Therapeutics, Inc.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
    Patent number: 11406663
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: August 9, 2022
    Assignee: Unicycive Therapeutics, Inc.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and Use
    Publication number: 20200093859
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: June 6, 2019
    Publication date: March 26, 2020
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
    Patent number: 10350240
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: July 16, 2019
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE
    Publication number: 20140161885
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: December 12, 2013
    Publication date: June 12, 2014
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale, Ramsharan Singh
  • LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE
    Publication number: 20110280956
    Abstract: The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.
    Type: Application
    Filed: May 12, 2011
    Publication date: November 17, 2011
    Applicant: SPECTRUM PHARMACEUTICALS, INC.
    Inventors: Ashok Yeshwant Gore, Milind Dixit, Ravichandran Mahalingam, Edward A. Schauer, Matthew Stewart, Rajendra Tandale
  • METHODS OF TREATING OCULAR DISORDERS
    Publication number: 20100216700
    Abstract: This invention is directed to treatments of ocular disorders using emulsions and molecular dispersions in the form of a gel comprising a hydrophobic ocular agent.
    Type: Application
    Filed: February 22, 2010
    Publication date: August 26, 2010
    Inventors: XIAOLING LI, Bhaskara Jasti, Ravichandran Mahalingam
  • Ocular Agent Delivery Systems
    Publication number: 20080132444
    Abstract: This invention is directed to novel ocular agent delivery systems and, in particular, emulsions and molecular dispersions in the form of a gel comprising a hydrophobic ocular agent.
    Type: Application
    Filed: September 29, 2005
    Publication date: June 5, 2008
    Inventors: Xiaoling Li, Bhaskara Jasti, Ravichandran Mahalingam